These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16506988)

  • 21. Nanotoxicology and nanomedicine: making hard decisions.
    Linkov I; Satterstrom FK; Corey LM
    Nanomedicine; 2008 Jun; 4(2):167-71. PubMed ID: 18329962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intelligent data collection tool for chemical safety/risk assessment.
    Verdonck FA; Van Sprang PA; Vanrolleghem PA
    Chemosphere; 2008 Feb; 70(10):1818-26. PubMed ID: 17959222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Workplace practices for engineered nanomaterial manufacturers.
    Woskie S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):685-92. PubMed ID: 20593453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stoffenmanager Nano version 1.0: a web-based tool for risk prioritization of airborne manufactured nano objects.
    Van Duuren-Stuurman B; Vink SR; Verbist KJ; Heussen HG; Brouwer DH; Kroese DE; Van Niftrik MF; Tielemans E; Fransman W
    Ann Occup Hyg; 2012 Jul; 56(5):525-41. PubMed ID: 22267129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk management of nanomaterials.
    Gwinn MR; Tran L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):130-7. PubMed ID: 20077523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health effects of nanomaterials.
    Tetley TD
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):527-31. PubMed ID: 17511644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures.
    Paik SY; Zalk DM; Swuste P
    Ann Occup Hyg; 2008 Aug; 52(6):419-28. PubMed ID: 18632731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of water quality management with a systematic qualitative uncertainty analysis.
    Chen CF; Ma HW; Reckhow KH
    Sci Total Environ; 2007 Mar; 374(1):13-25. PubMed ID: 17258295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Safety Walkround as a risk assessment tool: the first Italian experience].
    Levati A; Amato S; Adrario E; De Flaviis C; Delia C; Milesi S; Petrini F; Bevilacqua L
    Ig Sanita Pubbl; 2009; 65(3):227-40. PubMed ID: 19629149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A risk assessment framework for assessing metallic nanomaterials of environmental concern: aquatic exposure and behavior.
    O'Brien NJ; Cummins EJ
    Risk Anal; 2011 May; 31(5):706-26. PubMed ID: 21155861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing the ecological risk assessment process.
    Dale VH; Biddinger GR; Newman MC; Oris JT; Suter GW; Thompson T; Armitage TM; Meyer JL; Allen-King RM; Burton GA; Chapman PM; Conquest LL; Fernandez IJ; Landis WG; Master LL; Mitsch WJ; Mueller TC; Rabeni CF; Rodewald AD; Sanders JG; van Heerden IL
    Integr Environ Assess Manag; 2008 Jul; 4(3):306-13. PubMed ID: 18324871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health impact and safety of engineered nanomaterials.
    Teow Y; Asharani PV; Hande MP; Valiyaveettil S
    Chem Commun (Camb); 2011 Jul; 47(25):7025-38. PubMed ID: 21479319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent prevention strategies and occupational risk analysis: Control Banding and Sobane].
    Ghittori S; Ferrari M; Negri S; Serranti P; Sacco P; Biffi R; Imbriani M
    G Ital Med Lav Ergon; 2006; 28(1):30-43. PubMed ID: 16705887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical review of the safety assessment of nano-structured silica additives in food.
    Winkler HC; Suter M; Naegeli H
    J Nanobiotechnology; 2016 Jun; 14(1):44. PubMed ID: 27287345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncertainty analysis based on probability bounds (p-box) approach in probabilistic safety assessment.
    Karanki DR; Kushwaha HS; Verma AK; Ajit S
    Risk Anal; 2009 May; 29(5):662-75. PubMed ID: 19302279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Considerations for environmental fate and ecotoxicity testing to support environmental risk assessments for engineered nanoparticles.
    Tiede K; Hassellöv M; Breitbarth E; Chaudhry Q; Boxall AB
    J Chromatogr A; 2009 Jan; 1216(3):503-9. PubMed ID: 18805541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles and their biological and environmental applications.
    Liu WT
    J Biosci Bioeng; 2006 Jul; 102(1):1-7. PubMed ID: 16952829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing environmental harm: developments in an approach to strategic risk assessment and risk management.
    Pollard SJ; Kemp RV; Crawford M; Duarte-Davidson R; Irwin JG; Yearsley R
    Risk Anal; 2004 Dec; 24(6):1551-60. PubMed ID: 15660611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.